ATE65494T1 - Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften. - Google Patents

Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften.

Info

Publication number
ATE65494T1
ATE65494T1 AT87306988T AT87306988T ATE65494T1 AT E65494 T1 ATE65494 T1 AT E65494T1 AT 87306988 T AT87306988 T AT 87306988T AT 87306988 T AT87306988 T AT 87306988T AT E65494 T1 ATE65494 T1 AT E65494T1
Authority
AT
Austria
Prior art keywords
phenylamides
pharmaceutical properties
butene acid
butene
acid
Prior art date
Application number
AT87306988T
Other languages
English (en)
Inventor
Peter Thaddeus Gallagher
Terence Alan Hicks
Graham Walter Mullier
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of ATE65494T1 publication Critical patent/ATE65494T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C07D261/16—Benzene-sulfonamido isoxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT87306988T 1986-08-08 1987-08-06 Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften. ATE65494T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619432A GB8619432D0 (en) 1986-08-08 1986-08-08 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ATE65494T1 true ATE65494T1 (de) 1991-08-15

Family

ID=10602473

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87306988T ATE65494T1 (de) 1986-08-08 1987-08-06 Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften.

Country Status (23)

Country Link
US (1) US4892963A (de)
EP (1) EP0257882B1 (de)
JP (1) JPS63239259A (de)
KR (2) KR880002815A (de)
CN (1) CN1015256B (de)
AR (2) AR244660A1 (de)
AT (1) ATE65494T1 (de)
AU (1) AU604737B2 (de)
CA (1) CA1317964C (de)
DE (1) DE3771611D1 (de)
DK (1) DK169404B1 (de)
EG (1) EG18269A (de)
ES (1) ES2031510T3 (de)
GB (1) GB8619432D0 (de)
GR (1) GR3002714T3 (de)
HU (1) HU197559B (de)
IL (1) IL83432A (de)
MX (1) MX174371B (de)
NZ (1) NZ221352A (de)
PH (1) PH22821A (de)
PT (1) PT85476B (de)
RU (1) RU1771472C (de)
ZA (1) ZA875813B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US4975462A (en) * 1988-07-29 1990-12-04 Bristol-Myers Company Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
AU649421B2 (en) * 1990-05-18 1994-05-26 Sanofi-Aventis Deutschland Gmbh Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf 3-Cycloalkyl-prop-2- enamide derivatives
EP0538783B1 (de) * 1991-10-23 1995-09-27 Hoechst Aktiengesellschaft N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
TW314467B (de) * 1993-03-31 1997-09-01 Hoechst Ag
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
PT787491E (pt) * 1994-10-17 2000-11-30 Aventis Pharma Ltd Composicao para a profilaxia e para o tratamento de doencas alergicas de tipo i
DE19702988A1 (de) 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
HUP0204069A3 (en) * 1999-12-16 2005-01-28 Teva Pharma Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
EP1257270B1 (de) 2000-02-15 2005-04-13 Teva Pharmaceutical Industries Ltd. Methode zur synthetisierung von leflunomid
US6894184B2 (en) 2003-03-18 2005-05-17 Aventis Pharma Deutschland Gmbh Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides
DE10311763A1 (de) * 2003-03-18 2004-10-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden
WO2015077535A2 (en) 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK545976A (da) * 1975-12-11 1977-06-12 Hoechst Ag Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten
DE2655009A1 (de) * 1976-12-04 1978-06-15 Hoechst Ag Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
EP0021207B1 (de) * 1979-06-11 1985-08-07 Ciba-Geigy Ag Alphacarbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate die diese Verbindungen enthalten

Also Published As

Publication number Publication date
AU604737B2 (en) 1991-01-03
PT85476A (en) 1987-09-01
CN1015256B (zh) 1992-01-01
PT85476B (pt) 1990-06-29
DK413987D0 (da) 1987-08-07
NZ221352A (en) 1989-10-27
US4892963A (en) 1990-01-09
AR244660A1 (es) 1993-11-30
EG18269A (en) 1992-12-30
GB8619432D0 (en) 1986-09-17
EP0257882B1 (de) 1991-07-24
IL83432A (en) 1992-06-21
KR880002815A (ko) 1988-05-11
HU197559B (en) 1989-04-28
DK413987A (da) 1988-02-09
EP0257882A1 (de) 1988-03-02
HUT44523A (en) 1988-03-28
ES2031510T3 (es) 1992-12-16
KR880002823A (ko) 1988-05-11
IL83432A0 (en) 1988-01-31
MX7668A (es) 1993-08-01
ZA875813B (en) 1989-04-26
DK169404B1 (da) 1994-10-24
AU7668187A (en) 1988-02-11
JPS63239259A (ja) 1988-10-05
PH22821A (en) 1989-01-19
CN87105516A (zh) 1988-02-24
DE3771611D1 (de) 1991-08-29
AR247876A1 (es) 1995-04-28
RU1771472C (ru) 1992-10-23
GR3002714T3 (en) 1993-01-25
CA1317964C (en) 1993-05-18
MX174371B (es) 1994-05-11

Similar Documents

Publication Publication Date Title
DE3771611D1 (de) Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften.
DE3783437D1 (de) Heilmittel.
FI873113L (fi) Tvaettmedelskomposition.
DE3882848D1 (de) Kosmetikbasiszubereitung mit arzneimitteleigenschaften.
DE3683389D1 (de) Gewebeausweitungsvorrichtung mit mehreren huellen.
FI892435L (fi) Homogen skyddsbestaemningsmetod.
FI891370A0 (fi) Vattenloesliga fyllmedel.
DE3767909D1 (de) Bauelement mit akustischen eigenschaften.
DE3786247D1 (de) Lanzette mit rueckfuehrung.
FI874819L (fi) Human rekombinant endotelcell vaextfaktor.
DE68902561D1 (de) Feldhaecksler.
FI885026L (fi) Haorvaordsmedel.
DE3674593D1 (de) Medizinische zusammensetzung.
FI861358L (fi) Monoklonala antikroppar foer determinering av glykosylerat hemoglobin i blodet.
DE3765461D1 (de) Katheter mit einfuehrungshilfe.
FI893835L (fi) Laekemedel.
DE3583285D1 (de) Milbemycinderivate mit pestiziden eigenschaften.
DE3868866D1 (de) Ergolinderivate mit antiparkinsonwirkung.
DE3861529D1 (de) Arzneizubereitung mit indomethacin.
IT8820388A0 (it) Composizione oftalmologica.
DE68902669D1 (de) Feldhaecksler.
DE3685315D1 (de) Antivirus-heilmittel.
FI893279A0 (fi) Antivirusmedel samt kompositioner innehaollande desamma.
FI881238A7 (fi) Farmaceutisk beredning.
DE3880561D1 (de) Actinoninderivate mit physiologischen aktivitaeten.